
For more information, press only:
Bruce Hammond, Marketing, (800) 869-5992, admin@vidandiagnostics.com
Next Generation Beta-hydroxybutyrate Reagent For Beckman Coulter DxC 500 AU Clinical Chemistry System
Vidan Diagnostics makes β-Hydroxybutyrate 21 FS Assay
Available on Beckman DxC 500 AU
SAN ANTONIO, Texas, May 17, 2025 – Vidan Diagnostics, today announced that its β-Hydroxybutyrate 21 FS Next Generation Reagent can be easily programmed to perform testing on the Beckman DxC 500 AU clinical chemistry system. Beta-Hydroxybutyrate (BHB) is an important marker when used in conjunction with clinical findings and other laboratory tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA).
Beckman Coulter DxC 500 AU Reagent Application for Beta-Hydroxybutyrate
Vidan Diagnostics’ β-Hydroxybutyrate 21 FS Assay is a liquid stable, ready to use reagent that offers 8 weeks calibration and onboard stability when run on the Beckman DxC 500 AU clinical chemistry system. “Beckman Coulter is one of the leading clinical chemistry manufacturers in the U.S. With the addition of the application for the DxC 500 AU, customers now have the ability to perform our beta-hydroxybutyrate test across the entire line of Beckman clinical chemistry instruments”, said Gilbert Mejia, CEO of Vidan Diagnostics. “Our β-Hydroxybutyrate 21 FS is becoming the preferred test by customers and field application specialist alike, due to its many performance advantages and prefilled bottles that load directly onto the Beckman AU chemstry systems”, Mejia added.
Beta-Hydroxybutyrate
Beta-hydroxybutyrate is the predominate ketone body produced during Diabetic Ketoacidosis, (DKA) It’s relative proportion in the blood, (78%) is greater than the other two ketones, acetoacetate, (20%) and acetone, (2%) and is therefore the best indicator of DKA. DKA is a serious condition that can lead to diabetic coma or even death.
Founded in 2018, Vidan Diagnostics is a supplier of medical diagnostic products. It is focused on medical devices and reagents used for diagnosing and monitoring patients with conditions of diabetes, sepsis, anemia, heart disease and stroke. Vidan Diagnostics is dedicated to delivering proven and innovative products to all people in all places, in all aspects and stages of life with integrity and reliability. The company is headquartered in San Antonio, Texas.
For more information, press only:
Robert Sanderford, Marketing, (800) 869-5992, robbsanderford@vidandiagnostics.com
